878 results on '"Cassiman, David"'
Search Results
52. EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
53. Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias
54. Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review
55. Ageing in Liver Transplantation: Does the Interaction of Donor and Recipient Age Matter?
56. Response by Kusters et al to Letter Regarding Article, “Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)”
57. Pre‐operative trans‐catheter arterial chemo‐embolization increases hepatic artery thrombosis after liver transplantation – a retrospective study
58. Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network.
59. Liver transplantation for very severe hepatopulmonary syndrome due to vitamin A-induced chronic liver disease in a patient with Shwachman-Diamond syndrome
60. NTCP deficiency and persistently raised bile salts: an adult case
61. Ornithine transcarbamylase deficiency: A diagnostic odyssey
62. Uncovering monocyte transcription, functional and metabolic signatures in recovery and non-recovery ACLF patients
63. Clinical utility of non-ceruloplasmin copper determined by copper speciation for monitoring Wilson disease therapy: comparative data analysis with 24-hour urinary copper excretion from the CHELATE trial
64. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
65. Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives
66. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
67. Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles
68. A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge
69. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria:A comparison between two genetic disorders affecting the same metabolic pathway
70. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
71. On the Pathogenesis of Central Liver Nodules in Alagille Syndrome
72. Evaluating and improving orphan drug regulations in Europe: A Delphi policy study
73. Management dilemmas in pediatric nephrology: Cystinosis
74. Bone demineralisation in a large cohort of Wilson disease patients
75. A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge
76. CLINICAL AND BIOCHEMICAL FOOTPRINTS OF INHERITED METABOLIC DISORDERS: A LESSON FROM THE KNOWLEDGEBASE
77. Overlapping and divergent hepatic and lipoprotein phenotypes in untreated adults with acid sphingomyelinase deficiency versus untreated adults with Gaucher disease from two pivotal clinical trials
78. Liver disorders
79. Tyrosinemia Type I
80. Glycogen Storage Disorders
81. Approach to the Patient with Hepato-Gastroenterological or Abdominal Signs and Symptoms
82. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
83. Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series
84. Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications
85. Genotype-Phenotype Correlations in PMM2-CDG
86. Patents vs patients 1‐0: The case of chenodeoxycholic acid
87. S1063 Disease Burden in Patients With Acute Hepatic Porphyria: Experience From the Phase 3 ENVISION Study
88. Expert consensus statement on acute hepatic porphyria in Belgium
89. Frequency and pathogenesis of central liver nodules in Alagille syndrome patients
90. Hepatobiliary malignancies in Wilson disease
91. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis
92. Expert consensus statement on acute hepatic porphyria in Belgium.
93. Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up
94. Misdiagnosis as asphyxiating thoracic dystrophy and CMV-associated haemophagocytic lymphohistiocytosis in Shwachman-Diamond syndrome
95. Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease
96. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)
97. Additional file 1 of Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework
98. Orphan Drugs for Rare Diseases: Is it Time to Revisit Their Special Market Access Status?
99. Drugs for rare diseases: Influence of orphan designation status on price
100. The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.